MYNZ vs UNH

MYNZ presents an exceptionally high-risk, ultra-speculative scenario, even more so than previously assessed. The company has undergone a complete pivot, discontinuing its colorectal cancer screening business (ColoAlert IP is being sold) and shifting entirely to post-quantum cybersecurity (Quantum Cyber brand). This pivot is accompanied by a severe recapitalization event where existing shareholders...

UnitedHealth Group (UNH) remains a healthcare titan, but its sheer scale and the highly regulated nature of its operations fundamentally limit its 10x growth potential within 3-5 years. The recent Optum Health operating loss of $278M in 2025 (compared to $7.77B income in 2024) is a significant concern, eroding the growth narrative that Optum once provided. Furthermore, the proposed 0.09% Medicare ...